Puretech Health PLC
A clinical-stage biotherapeutics company developing new medicines for devastating diseases.
PRTC | IL
Overview
Corporate Details
- ISIN(s):
- GB00BPVG5C82 (+2 more)
- LEI:
- 213800LVPDNO2Z9T9I39
- Country:
- United States of America
- Address:
- 6 TIDE STREET, 02210 BOSTON
- Website:
- https://www.puretechhealth.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Puretech Health PLC is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicines to treat devastating diseases. Operating on a 'hub-and-spoke' model, the company leverages its internal R&D engine and collaborations with leading scientific experts to create and advance a diverse portfolio of therapeutic candidates. Puretech's approach focuses on enhancing on-target efficacy, improving tolerability, and enabling oral administration to unlock the full potential of proven biological mechanisms. The company has a strong track record of clinical success, having advanced numerous therapeutics from inception through clinical development and regulatory review.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-23 18:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 25.0 KB | ||
| 2025-09-19 08:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 66.6 KB | ||
| 2025-09-11 13:05 |
Regulatory News Service
PRTC's Seaport Advances 2nd Candidate Into Clinic
|
English | 29.4 KB | ||
| 2025-09-04 18:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 25.0 KB | ||
| 2025-08-21 13:00 |
Regulatory News Service
PureTech Showcases Differentiated IPF Strategy
|
English | 34.6 KB | ||
| 2025-08-18 08:00 |
Report Publication Announcement
Notice of Results
|
English | 8.8 KB | ||
| 2025-08-13 18:12 |
Regulatory News Service
PRTC's Vedanta Announces VE202 Phase 2 Results
|
English | 23.1 KB | ||
| 2025-08-12 13:00 |
Business and Financial Review
PRTC Launches Celea to Advance Ph3-Ready IPF Drug
|
English | 22.0 KB | ||
| 2025-08-05 18:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.1 KB | ||
| 2025-08-01 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 9.8 KB | ||
| 2025-07-17 13:05 |
Regulatory News Service
PRTC’s Seaport Begins Phase 2b Study in MDD
|
English | 27.4 KB | ||
| 2025-07-16 08:00 |
Board/Management Information
PureTech Announces Leadership Transition
|
English | 13.9 KB | ||
| 2025-07-04 18:30 |
Director's Dealing
PDMR Notification
|
English | 22.3 KB | ||
| 2025-07-04 18:30 |
Director's Dealing
PDMR Notification RSU Vesting
|
English | 24.5 KB | ||
| 2025-07-04 18:30 |
Remuneration Information
PDMR Notification RSU Vesting
|
English | 24.0 KB |
Automate Your Workflow. Get a real-time feed of all Puretech Health PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Puretech Health PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
